Asthma in sickle cell disease: Implications for treatment

Anemia

Volumn 2011, Issue , 2011, Pages

  Blake, Kathryn ^a   Lima, John ^a  

^a NEMOURS CHILDREN S CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84873081757     PISSN: 20901267     EISSN: 20901275     Source Type: Journal    
DOI: 10.1155/2011/740235     Document Type: Review

References (149)

1. Hassell K. L., Population estimates of sickle cell disease in the U.S. American Journal of Preventive Medicine 2010 38 4 S512 S521 2-s2.0-77949482609 10.1016/j.amepre.2009.12.022
2. Ashley-Koch A., Yang Q., Olney R. S., Sickle hemoglobin (Hb S) allele and sickle cell disease: a HuGE review. American Journal of Epidemiology 2000 151 9 839 845 2-s2.0-0034178262 (Pubitemid 30461125)
3. Olney R. S., Newborn screening for sickle cell disease: public health impact and evaluation. Part IV. Developing, Implementing, and Evaluating Population Interventions 2000 chapter 22 Oxford, UK Oxford University Press. http://www.cdc.gov/genomics/resources/books/21stcent/chap22.htm
4. Trends in Asthma morbidity and mortality-January 2009. American Lung Association Epidemiology & Statistics Unit Research Epidemiology & Statistics Unit, January 2009
5. Akinbami L., The state of childhood asthma, United States, 1980-2005. Advance data 2006 381 1 24 2-s2.0-33947325340
6. Vichinsky E. P., evichinsky@mail.cho.org Neumayr L. D., Earles A. N., Williams R., Lennette E. T., Dean D., Nickerson B., Orringer E., McKie V., Bellevue R., Daeschner C., Manci E. A., Abboud M., Moncino M., Ballas S., Ware R., Causes and outcomes of the acute chest syndrome in sickle cell disease. New England Journal of Medicine 2000 342 25 1855 1865 10.1056/NEJM200006223422502 (Pubitemid 30419049)
7. Leong M. A., Dampier C., Varlotta L., Allen J. L., Airway hyperreactivity in children with sickle cell disease. Journal of Pediatrics 1997 131 2 278 285 2-s2.0-0030657413 10.1016/S0022-3476(97)70166-5 (Pubitemid 27495250)
8. Knight-Madden J. M., Forrester T. S., Lewis N. A., Greenough A., Asthma in children with sickle cell disease and its association with acute chest syndrome. Thorax 2005 60 3 206 210 2-s2.0-14944365672 10.1136/thx.2004.029165 (Pubitemid 40380278)
9. Koumbourlis A. C., Zar H. J., Hurlet-Jensen A., Goldberg M. R., Prevalence and reversibility of lower airway obstruction in children with sickle cell disease. Journal of Pediatrics 2001 138 2 188 192 2-s2.0-0035136308 10.1067/mpd.2001.111824 (Pubitemid 32156432)
10. Sylvester K. P., Patey R. A., Rafferty G. F., Rees D., Thein S. L., Greenough A., Airway hyperresponsiveness and acute chest syndrome in children with sickle cell anemia. Pediatric Pulmonology 2007 42 3 272 276 2-s2.0-33947243337 10.1002/ppul.20571 (Pubitemid 46417701)
11. Ozbek O. Y., Malbora B., Sen N., Yazici A. C., Ozyurek E., Ozbek N., Airway hyperreactivity detected by methacholine challenge in children with sickle cell disease. Pediatric Pulmonology 2007 42 12 1187 1192 2-s2.0-36849032859 10.1002/ppul.20716 (Pubitemid 350231870)
12. Bryant R., Asthma in the pediatric sickle cell patient with acute chest syndrome. Journal of Pediatric Health Care 2005 19 3 157 162 2-s2.0-18144410933 10.1016/j.pedhc.2004.12.003 (Pubitemid 40616271)
13. Strunk R. C., Brown M. S., Boyd J. H., Bates P., Field J. J., DeBaun M. R., Methacholine challenge in children with sickle cell disease: a case series. Pediatric Pulmonology 2008 43 9 924 929 2-s2.0-50849095239 10.1002/ppul.20884
14. Field J. J., Stocks J., Kirkham F. J., Airway hyper-responsiveness in children with sickle cell anemia. Chest. In press
15. Field J. J., Macklin E. A., Yan Y., Strunk R. C., DeBaun M. R., Sibling history of asthma is a risk factor for pain in children with sickle cell anemia. American Journal of Hematology 2008 83 11 855 857 2-s2.0-55549139821 10.1002/ajh.21275
16. Phillips K. L., An P., Boyd J. H., Strunk R. C., Casella J. F., Barton B. A., Debaun M. R., Major gene effect and additive familial pattern of inheritance of asthma exist among families of probands with sickle cell anemia and asthma. American Journal of Human Biology 2008 20 2 149 153 2-s2.0-41149103976 10.1002/ajhb.20703 (Pubitemid 351425240)
17. Boyd J. H., Macklin E. A., Strunk R. C., DeBaun M. R., Asthma is associated with increased mortality in individuals with sickle cell anemia. Haematologica 2007 92 8 1115 1118 2-s2.0-35748980612 10.3324/haematol.11213 (Pubitemid 350144219)
18. Duckworth L., Hsu L., Feng H., Wang J., Sylvester J. E., Kissoon N., Sandler E., Lima J. J., Physician-diagnosed asthma and acute chest syndrome: associations with NOS polymorphisms. Pediatric Pulmonology 2007 42 4 332 338 2-s2.0-34247193669 10.1002/ppul.20582 (Pubitemid 46608902)
19. Bernaudin F., Strunk R. C., Kamdem A., Arnaud C., An P., Torres M., Delacourt C., DeBaun M. R., Asthma is associated with acute chest syndrome, but not with an increased rate of hospitalization for pain among children in France with sickle cell anemia: a retrospective cohort study. Haematologica 2008 93 12 1917 1918 2-s2.0-57349158830 10.3324/haematol.13090
20. Boyd J. H., Macklin E. A., Strunk R. C., DeBaun M. R., Asthma is associated with acute chest syndrome and pain in children with sickle cell anemia. Blood 2006 108 9 2923 2927 2-s2.0-33747479576 10.1182/blood-2006-01- 011072
21. Sylvester K. P., Patey R. A., Broughton S., Rafferty G. F., Rees D., Thein S. L., Greenough A., Temporal relationship of asthma to acute chest syndrome in sickle cell disease. Pediatric Pulmonology 2007 42 2 103 106 2-s2.0-33846796350 10.1002/ppul.20430 (Pubitemid 46214564)
22. Quinn C. T., Shull E. P., Ahmad N., Lee N. J., Rogers Z. R., Buchanan G. R., Prognostic significance of early vaso-occlusive complications in children with sickle cell anemia. Blood 2007 109 1 40 45 2-s2.0-33846006850 10.1182/blood-2006-02-005082 (Pubitemid 46053040)
23. Darbari D. S., Kple-Faget P., Kwagyan J., Rana S., Gordeuk V. R., Castro O., Circumstances of death in adult sickle cell disease patients. American Journal of Hematology 2006 81 11 858 863 2-s2.0-33750600143 10.1002/ajh.20685 (Pubitemid 44682188)
24. Fitzhugh C. D., Lauder N., Jonassaint J. C., Telen M. J., Zhao X., Wright E. C., Gilliam F. R., De Castro L. M., Cardiopulmonary complications leading to premature deaths in adult patients with sickle cell disease. American Journal of Hematology 2010 85 1 36 40 2-s2.0-74049151134 10.1002/ajh.21569
25. Zimmermann N., Rothenberg M. E., The arginine-arginase balance in asthma and lung inflammation. European Journal of Pharmacology 2006 533 1-3 253 262 2-s2.0-33644769084 10.1016/j.ejphar.2005.12.047 (Pubitemid 43340017)
26. Vercelli D., Arginase: marker, effector, or candidate gene for asthma? Journal of Clinical Investigation 2003 111 12 1815 1817 2-s2.0-0042243559 10.1172/JCI200318908 (Pubitemid 38057724)
27. ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005. American Journal of Respiratory and Critical Care Medicine 2005 171 8 912 930
28. Smith A. D., Cowan J. O., Brassett K. P., Herbison G. P., Taylor D. R., Use of exhaled nitric oxide measurements to guide treatment in chronic asthma. New England Journal of Medicine 2005 352 21 2163 2173 2-s2.0-19444385389 10.1056/NEJMoa043596 (Pubitemid 40727083)
29. Kharitonov S. A., Yates D., Robbins R. A., Logan-Sinclair R., Shinebourne E. A., Barnes P. J., Increased nitric oxide in exhaled air of asthmatic patients. Lancet 1994 343 8890 133 135 2-s2.0-0028053173 10.1016/S0140-6736(94) 90931-8 (Pubitemid 24028638)
30. Kharitonov S. A., Yates D. H., Barnes P. J., Inhaled glucocorticoids decrease nitric oxide in exhaled air of asthmatic patients. American Journal of Respiratory and Critical Care Medicine 1996 153 1 454 457 2-s2.0-0030022873 (Pubitemid 26026889)
31. Morris C. R., Gladwin M. T., Kato G. J., Nitric oxide and arginine dysregulation: a novel pathway to pulmonary hypertension in hemolytic disorders. Current Molecular Medicine 2008 8 7 620 632 2-s2.0-59249083671 10.2174/156652408786241447
32. Morris C. R., Asthma management: reinventing the wheel in sickle cell disease. American Journal of Hematology 2009 84 4 234 241 2-s2.0-64549106465 10.1002/ajh.21359
33. Sullivan K. J., Kissoon N., Duckworth L. J., Sandler E., Freeman B., Bayne E., Sylvester J. E., Lima J. J., Low exhaled nitric oxide and a polymorphism in the NOS I gene is associated with acute chest syndrome. American Journal of Respiratory and Critical Care Medicine 2002 164 12 2186 2190 2-s2.0-0037114210
34. Sullivan K. J., Kissoon N., Sandler E., Gauger C., Froyen M., Duckworth L., Brown M., Murphy S., Effect of oral arginine supplementation on exhaled nitric oxide concentration in sickle cell anemia and acute chest syndrome. Journal of Pediatric Hematology/Oncology 2010 32 7 e249 e258
35. Girgis R. E., Qureshi M. A., Abrams J., Swerdlow P., Decreased exhaled nitric oxide in sickle cell disease: relationship with chronic lung involvement. American Journal of Hematology 2003 72 3 177 184 2-s2.0-0037371369 10.1002/ajh.10284 (Pubitemid 36258608)
36. Pawar S. S., Panepinto J. A., Brousseau D. C., The effect of acute pain crisis on exhaled nitric oxide levels in children with sickle cell disease. Pediatric Blood and Cancer 2008 50 1 111 113 2-s2.0-36849095988 10.1002/pbc.20872 (Pubitemid 350234274)
37. Niscola P., Sorrentino F., Scaramucci L., de Fabritiis P., Cianciulli P., Pain syndromes in sickle cell disease: an update. Pain Medicine 2009 10 3 470 480 2-s2.0-65349129462 10.1111/j.1526-4637.2009.00601.x
38. Jacob E., Sockrider M. M., Dinu M., Acosta M., Mueller B. U., Respiratory symptoms and acute painful episodes in sickle cell disease. Journal of Pediatric Oncology Nursing 2010 27 1 33 39 2-s2.0-73949092372 10.1177/1043454209344578
39. Shapiro B. S., Dinges D. F., Orne E. C., Bauer N., Reilly L. B., Whitehouse W. G., Ohene-Frempong K., Orne M. T., Home management of sickle cell-related pain in children and adolescents: natural history and impact on school attendance. Pain 1995 61 1 139 144 2-s2.0-0028905641 10.1016/0304- 3959(94)00164-A
40. Dampier C., Setty B. N. Y., Eggleston B., Brodecki D., O'Neal P., Stuart M., Vaso-occlusion in children with sickle cell disease: clinical characteristics and biologic correlates. Journal of Pediatric Hematology/Oncology 2004 26 12 785 790 2-s2.0-10944233777 (Pubitemid 40019176)
41. Glassberg J., Spivey J. F., Strunk R., Boslaugh S., DeBaun M. R., Painful episodes in children with sickle cell disease and asthma are temporally associated with respiratory symptoms. Journal of Pediatric Hematology/Oncology 2006 28 8 481 485 2-s2.0-33747478249 10.1097/01.mph.0000212968.98501.2b (Pubitemid 44257993)
42. Holgate S. T., Pathogenesis of asthma. Clinical and Experimental Allergy 2008 38 6 872 897 2-s2.0-47949119866 10.1111/j.1365-2222.2008.02971.x
43. Platt O. S., Sickle cell anemia as an inflammatory disease. Journal of Clinical Investigation 2000 106 3 337 338 2-s2.0-0033837987 (Pubitemid 30655633)
44. Drazen J. M., Israel E., O'Byrne P. M., Treatment of asthma with drugs modifying the leukotriene pathway. New England Journal of Medicine 1999 340 3 197 206 2-s2.0-0033590513 10.1056/NEJM199901213400306 (Pubitemid 29063217)
45. Kanaoka Y., Boyce J. A., Cysteinyl leukotrienes and their receptors: cellular distribution and function in immune and inflammatory responses. Journal of Immunology 2004 173 3 1503 1510 2-s2.0-3242807236 (Pubitemid 38971578)
46. Woods J. W., Evans J. F., Ethier D., Scott S., Vickers P. J., Hearn L., Heibein J. A., Charleson S., Singer I. I., 5-lipoxygenase and 5-lipoxygenase-activating protein are localized in the nuclear envelope of activated human leukocytes. Journal of Experimental Medicine 1993 178 6 1935 1946 2-s2.0-0027504207 10.1084/jem.178.6.1935 (Pubitemid 23344852)
47. Lam B. K., Owen W. F., Austen K. F., Soberman R. J., The identification of a distinct export step following the biosynthesis of leukotriene C by human eosinophils. Journal of Biological Chemistry 1989 264 22 12885 12889 2-s2.0-0024392871 (Pubitemid 19194859)
48. Anderson M. E., Allison R. D., Meister A., Interconversion of leukotrienes catalyzed by purified γ -glutamyl transpeptidase: concomitant formation of leukotriene D4 and γ -glutamyl amino acids. Proceedings of the National Academy of Sciences of the United States of America 1982 79 4 1088 1091 2-s2.0-0012963984 (Pubitemid 12114070)
49. Lee C. W., Lewis R. A., Corey E. J., Austen K. F., Conversion of leukotriene D to leukotriene E by a dipeptidase released from the specific granule of human polymorphonuclear leukocytes. Immunology 1983 48 1 27 35 2-s2.0-0020646863 (Pubitemid 13167975)
50. Rabinovitch N., Urinary leukotriene E. Immunology and Allergy Clinics of North America 2007 27 4 651 664 2-s2.0-35748984138 10.1016/j.iac.2007.09.004 (Pubitemid 350051337)
51. Folco G., Murphy R. C., Eicosanoid transcellular biosynthesis: from cell-cell interactions to in vivo tissue responses. Pharmacological Reviews 2006 58 3 375 388 2-s2.0-33748684386 10.1124/pr.58.3.8 (Pubitemid 44394907)
52. Nandedkar S. D., Feroah T. R., Hutchins W., Weihrauch D., Konduri K. S., Wang J., Strunk R. C., DeBaun M. R., Hillery C. A., Pritchard K. A., Histopathology of experimentally induced asthma in a murine model of sickle cell disease. Blood 2008 112 6 2529 2538 2-s2.0-55249127378 10.1182/blood-2008-01- 132506
53. Setty B. N. Y., Stuart M. J., Eicosanoids in sickle cell disease: potential relevance of neutrophil leukotriene B to disease pathophysiology. Journal of Laboratory and Clinical Medicine 2002 139 2 80 89 2-s2.0-0036009342 10.1067/mlc.2002.121200 (Pubitemid 34253461)
54. Ibe B. O., Kurantsin-Mills J., Raj J. U., Lessin L. S., Plasma and urinary leukotrienes in sickle cell disease: possible role in the inflammatory process. European Journal of Clinical Investigation 1994 24 1 57 64 2-s2.0-0028356681 (Pubitemid 24204955)
55. Field J. J., Strunk R. C., Knight-Perry J. E., Blinder M. A., Townsend R. R., DeBaun M. R., Urinary cysteinyl leukotriene E significantly increases during pain in children and adults with sickle cell disease. American Journal of Hematology 2009 84 4 231 233 2-s2.0-64549155231 10.1002/ajh.21370
56. Field J. J., Krings J., White N. L., Yan Y., Blinder M. A., Strunk R. C., Debaun M. R., Urinary cysteinyl leukotriene e is associated with increased risk for pain and acute chest syndrome in adults with sickle cell disease. American Journal of Hematology 2009 84 3 158 160 2-s2.0-62949207155 10.1002/ajh.21348
57. Jennings J. E., Ramkumar T., Mao J., Boyd J., Castro M., Field J. J., Strunk R. C., DeBaun M. R., Elevated urinary leukotriene E levels are associated with hospitalization for pain in children with sickle cell disease. American Journal of Hematology 2008 83 8 640 643 2-s2.0-49149105638 10.1002/ajh.21199
58. Drazen J. M., Austen K. F., Leukotrienes and airway responses. American Review of Respiratory Disease 1987 136 4 985 998 2-s2.0-0023589276 (Pubitemid 18028627)
59. Thompson M. D., Takasaki J., Capra V., Rovati G. E., Siminovitch K. A., Burnham W. M., Hudson T. J., Bossé Y., Cole D. E. C., G-protein-coupled receptors and asthma endophenotypes: the cysteinyl leukotriene system in perspective. Molecular Diagnosis and Therapy 2006 10 6 353 366 2-s2.0-33845513409 (Pubitemid 44927049)
60. In K. H., Asano K., Beier D., Grobholz J., Finn P. W., Silverman E. K., Silverman E. S., Collins T., Fischer A. R., Keith T. P., Serino K., Kim S. W., De Sanctis G. T., Yandava C., Pillari A., Rubin P., Kemp J., Israel E., Busse W., Ledford D., Murray J. J., Segal A., Tinkleman D., Drazen J. M., Naturally occurring mutations in the human 5-lipoxygenase gene promoter that modify transcription factor binding and reporter gene transcription. Journal of Clinical Investigation 1997 99 5 1130 1137 2-s2.0-0031003816 (Pubitemid 27123651)
61. Vikman S., Brena R. M., Armstrong P., Hartiala J., Stephensen C. B., Allayee H., Functional analysis of 5-lipoxygenase promoter repeat variants. Human Molecular Genetics 2009 18 23 4521 4529 2-s2.0-70449386908 10.1093/hmg/ddp414
62. Kalayci O., Birben E., Sackesen C., Keskin O., Tahan F., Wechsler M. E., Civelek E., Soyer O. U., Adalioglu G., Tuncer A., Israel E., Lilly C., ALOX5 promoter genotype, asthma severity and LTC production by eosinophils. Allergy 2006 61 1 97 103 2-s2.0-33644885331 10.1111/j.1398-9995.2006.00979.x (Pubitemid 43381198)
63. Patel N., Gonsalves C. S., Yang M., Malik P., Kalra V. K., Placenta growth factor induces 5-lipoxygenase-activating protein to increase leukotriene formation in sickle cell disease. Blood 2009 113 5 1129 1138 2-s2.0-60849115556 10.1182/blood-2008-07-169821
64. Perelman N., Selvaraj S. K., Batra S., Luck L. R., Erdreich-Epstein A., Coates T. D., Kalra V. K., Malik P., Placenta growth factor activates monocytes and correlates with sickle cell disease severity. Blood 2003 102 4 1506 1514 2-s2.0-0043156082 10.1182/blood-2002-11-3422 (Pubitemid 36988063)
65. Freishtat R. J., Iqbal S. F., Pillai D. K., Klein C. J., Ryan L. M., Benton A. S., Teach S. J., High prevalence of vitamin D deficiency among inner-city African American youth with asthma in Washington, DC. Journal of Pediatrics 2010 156 6 948 952 2-s2.0-77952291218 10.1016/j.jpeds.2009.12.033
66. Beasley R., The burden of asthma with specific reference to the United States. Journal of Allergy and Clinical Immunology 2002 109 5 S482 S489 2-s2.0-0036246458 10.1067/mai.2002.122716 (Pubitemid 34499500)
67. Camargo C. A. Jr., Rifas-Shiman S. L., Litonjua A. A., Rich-Edwards J. W., Weiss S. T., Gold D. R., Kleinman K., Gillman M. W., Maternal intake of vitamin D during pregnancy and risk of recurrent wheeze in children at 3 y of age. American Journal of Clinical Nutrition 2007 85 3 788 795 2-s2.0-33847781084 (Pubitemid 46393511)
68. Brehm J. M., Celedón J. C., Soto-Quiros M. E., Avila L., Hunninghake G. M., Forno E., Laskey D., Sylvia J. S., Hollis B. W., Weiss S. T., Litonjua A. A., Serum vitamin D levels and markers of severity of childhood asthma in Costa Rica. American Journal of Respiratory and Critical Care Medicine 2009 179 9 765 771 2-s2.0-65549154321 10.1164/rccm.200808-1361OC
69. Sutherland E. R., Goleva E., Jackson L. P., Stevens A. D., Leung D. Y. M., Vitamin D levels, lung function, and steroid response in adult asthma. American Journal of Respiratory and Critical Care Medicine 2010 181 7 699 704 2-s2.0-77951540657 10.1164/rccm.200911-1710OC
70. Goodman B. M. III, Artz N., Radford B., Chen I. A., Prevalence of vitamin D deficiency in adults with sickle cell disease. Journal of the National Medical Association 2010 102 4 332 335 2-s2.0-77951846598
71. Chapelon E., Garabedian M., Brousse V., Souberbielle J. C., Bresson J. L., de Montalembert M., Osteopenia and vitamin D deficiency in children with sickle cell disease. European Journal of Haematology 2009 83 6 572 578 2-s2.0-70449487214 10.1111/j.1600-0609.2009.01333.x
72. Rovner A. J., Stallings V. A., Kawchak D. A., Schall J. I., Ohene-Frempong K., Zemel B. S., High risk of vitamin D deficiency in children with sickle cell disease. Journal of the American Dietetic Association 2008 108 9 1512 1516 2-s2.0-49849104389 10.1016/j.jada.2008.06.433
73. Adewoye A. H., Chen T. C., Ma Q., McMahon L., Mathieu J., Malabanan A., Steinberg M. H., Holick M. F., Sickle cell bone disease: response to vitamin D and calcium. American Journal of Hematology 2008 83 4 271 274 2-s2.0-41449097387 10.1002/ajh.21085 (Pubitemid 351458003)
74. Lal A., Fung E. B., Pakbaz Z., Hackney-Stephens E., Vichinsky E. P., Bone mineral density in children with sickle cell anemia. Pediatric Blood and Cancer 2006 47 7 901 906 2-s2.0-33750466901 10.1002/pbc.20681 (Pubitemid 44656112)
75. Buison A. M., Kawchak D. A., Schall J., Ohene-Frempong K., Stallings V. A., Zemel B. S., Low vitamin D status in children with sickle cell disease. Journal of Pediatrics 2004 145 5 622 627 2-s2.0-7444220086 10.1016/j.jpeds.2004. 06.055 (Pubitemid 39440940)
76. Stinson J., Naser B., Pain management in children with sickle cell disease. Pediatric Drugs 2003 5 4 229 241 2-s2.0-0037269859 (Pubitemid 36469931)
77. Yoon S. L., Black S., Comprehensive, integrative management of pain for patients with sickle-cell disease. Journal of Alternative and Complementary Medicine 2006 12 10 995 1001 2-s2.0-33846262044 10.1089/acm.2006.12.995 (Pubitemid 46095127)
78. Farquhar H., Stewart A., Mitchell E., Crane J., Eyers S., Weatherall M., Beasley R., The role of paracetamol in the pathogenesis of asthma. Clinical and Experimental Allergy 2010 40 1 32 41 2-s2.0-72949117648 10.1111/j.1365-2222. 2009.03378.x
79. Beasley R. W., Clayton T. O., Crane J., Acetaminophen use and risk of asthma, rhinoconjunctivitis and eczema in adolescents: ISAAC phase three. American Journal of Respiratory and Critical Care Medicine. In press
80. Beasley R., Clayton T., Crane J., von Mutius E., Lai C. K., Montefort S., Stewart A., Association between paracetamol use in infancy and childhood, and risk of asthma, rhinoconjunctivitis, and eczema in children aged 6-7 years: analysis from Phase Three of the ISAAC programme. The Lancet 2008 372 9643 1039 1048 2-s2.0-52049087357 10.1016/S0140-6736(08)61445-2
81. Persky V. W., Acetaminophen and Asthma. Thorax 2010 65 2 99 100 2-s2.0-76549117654 10.1136/thx.2009.127977
82. Perzanowski M. S., Miller R. L., Tang D., Ali D., Garfinkel R. S., Chew G. L., Goldstein I. F., Perera F. P., Barr R. G., Prenatal acetaminophen exposure and risk of wheeze at age 5 years in an urban low-income cohort. Thorax 2010 65 2 118 123 2-s2.0-76549108770 10.1136/thx.2009.121459
83. EPR 3. National Asthma Education and Prevention Program, Expert Panel Report 3: Guidelines for the diagnosis and management of asthma August 2007 Bethesda, Md, USA U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health, National Heart, Lung, and Blood Institute. no. 08-4051
84. Field J. J., DeBaun M. R., Asthma and sickle cell disease: two distinct diseases or part of the same process? Hematology/American Society of Hematology. Education Program 2009 45 53 2-s2.0-77949436543
85. Schroeder S. A., Nepo A. G., Treatment of asthma in children with sickle cell disease can prevent recurrences of acute chest syndrome. American Journal of Respiratory and Critical Care Medicine 2008 177, article A262
86. Giuntini C. G., Paggiaro P. L., Present state of the controversy about regular inhaled β -agonists in asthma. European Respiratory Journal 1995 8 5 673 678 2-s2.0-0029068390
87. Sears M. R., Sly R. M., O'Donnell R., Relationships between asthma mortality and treatment. Annals of Allergy 1993 70 5 425 426 2-s2.0-0027310665
88. Inman W. H., Adelstein A. M., Rise and fall of asthma mortality in England and Wales in relation to use of pressurised aerosols. Lancet 1969 2 7615 279 285 2-s2.0-0014669064
89. Pearce N., Beasley R., Crane J., Burgess C., Jackson R., End of the New Zealand asthma mortality epidemic. Lancet 1995 345 8941 41 44 2-s2.0-0028887981
90. Spitzer W. O., Suissa S., Ernst P., Horwitz R. I., Habbick B., Cockcroft D., Boivin J. F., McNutt M., Buist A. S., Rebuck A. S., The use of β -agonists and the risk of death and near death from asthma. New England Journal of Medicine 1992 326 8 501 506 2-s2.0-0026595475
91. Drazen J. M., Israel E., Boushey H. A., Chinchilli V. M., Fahy J. V., Fish J. E., Lazarus S. C., Lemanske R. F., Martin R. J., Peters S. P., Sorkness C., Szefler S. J., Cherniak R., Hurd S., Comparison of regularly scheduled with as-needed use of albuterol in mild asthma. New England Journal of Medicine 1996 335 12 841 847 10.1056/NEJM199609193351202 (Pubitemid 26304065)
92. 2-adrenergic receptor impart distinct agonist-promoted regulatory properties. Biochemistry 1994 33 32 9414 9419 (Pubitemid 24272896)
93. Green S. A., Turki J., Bejarano P., Hall I. P., Liggett S. B., Influence of beta 2-adrenergic receptor genotypes on signal transduction in human airway smooth muscle cells. American Journal of Respiratory Cell and Molecular Biology 1995 13 1 25 33 2-s2.0-0029339086
94. 2-adrenergic receptor on the response to regular use of albuterol in asthma. American Journal of Respiratory and Critical Care Medicine 2000 162 1 75 80 2-s2.0-0033915078 (Pubitemid 30469801)
95. 2 adrenoceptor polymorphism. Thorax 2000 55 9 762 767 2-s2.0-0033841788 10.1136/thorax.55.9.762 (Pubitemid 30660904)
96. 2-adrenoceptor haplotypes at positions 16 and 27. British Journal of Clinical Pharmacology 2004 57 1 100 104 2-s2.0-0346688577 10.1046/j.1365-2125. 2003.01978.x (Pubitemid 38067956)
97. 2-adrenoceptor and the response to long-term β -agonist therapy in asthma. European Respiratory Journal 1998 11 3 589 593 2-s2.0-0031597001 (Pubitemid 28194848)
98. Israel E., Chinchilli V. M., Ford J. G., Boushey H. A., Cherniack R., Craig T. J., Deykin A., Fagan J. K., Fahy J. V., Fish J., Kraft M., Kunselman S. J., Lazarus S. C., Lemanske R. F., Liggett S. B., Martin R. J., Mitra N., Peters S. P., Silverman E., Sorkness C. A., Szefler S. J., Wechsler M. E., Weiss S. T., Drazen J. M., Use of regularly scheduled albuterol treatment in asthma: genotype-stratified, randomised, placebo-controlled cross-over trial. Lancet 2004 364 9444 1505 1512 2-s2.0-6944232728 10.1016/S0140-6736(04)17273-5 (Pubitemid 39410416)
99. Hawkins G. A., Tantisira K., Meyers D. A., Ampleford E. J., Moore W. C., Klanderman B., Liggett S. B., Peters S. P., Weiss S. T., Bleecker E. R., Sequence, haplotype, and association analysis of ADR β 2 in a multiethnic asthma case-control study. American Journal of Respiratory and Critical Care Medicine 2006 174 10 1101 1109 2-s2.0-33751087760 10.1164/rccm.200509-1405OC (Pubitemid 44772080)
100. Bleecker E. R., Lawrance R. M., Ambrose H. J., Goldman M., Beta2-adrenergic receptor gene polymorphisms: is Arg/Arg genotype associated with serious adverse events during treatment with budesonide and formoterol in one pressurized metered-dose inhaler (BUD/FM pMDI) within racial groups? American Journal of Respiratory and Critical Care Medicine 2008 177, article A775
101. Blake K., Madabushi R., Derendorf H., Lima J., Population pharmacodynamic model of bronchodilator response to inhaled albuterol in children and adults with asthma. Chest 2008 134 5 981 989 2-s2.0-55649094173 10.1378/chest.07-2991
102. Hardie G. E., Brown J. K., Gold W. M., Adrenergic responsiveness: FEV1 and symptom differences in Whites and African Americans with mild asthma. Journal of Asthma 2007 44 8 621 628 2-s2.0-35448956413 10.1080/02770900701540481 (Pubitemid 47621479)
103. 2 agonists. American Journal of Cardiology 2008 102 7 871 874 2-s2.0-52349122918 10.1016/j.amjcard.2008.05.029
104. Salpeter S. R., Ormiston T. M., Salpeter E. E., Cardiovascular effects of β -agonists in patients with asthma and COPD: a meta-analysis. Chest 2004 125 6 2309 2321 2-s2.0-2942744546 10.1378/chest.125.6.2309 (Pubitemid 38796452)
105. Mueller B. U., Martin K. J., Dreyer W., Bezold L. I., Mahoney D. H., Prolonged QT interval in pediatric sickle cell disease. Pediatric Blood and Cancer 2006 47 6 831 833 2-s2.0-33749164463 10.1002/pbc.20539 (Pubitemid 44476762)
106. Akgül F., Seyfeli E., Melek I., Duman T., Seydaliyeva T., Gali E., Yalçin F., Increased QT dispersion in sickle cell disease: effect of pulmonary hypertension. Acta Haematologica 2007 118 1 1 6 2-s2.0-34347351317 10.1159/000100929 (Pubitemid 47014333)
107. Kelly H. W., Non-corticosteroid therapy for long-term control of asthma. Expert Opinion on Pharmacotherapy 2007 8 13 2077 2087 2-s2.0-34548617019 10.1517/14656566.8.13.2077 (Pubitemid 47505586)
108. Rohrman B. A., Mazziotti D. A., Quantum chemical design of hydroxyurea derivatives for the treatment of sickle-cell anemia. Journal of Physical Chemistry B 2005 109 27 13392 13396 2-s2.0-22944450314 10.1021/jp0505429 (Pubitemid 41048749)
109. Haynes J. Jr., Obiako B., King J. A., Hester R. B., Ofori-Acquah S., Activated neutrophil-mediated sickle red blood cell adhesion to lung vascular endothelium: role of phosphatidylserine-exposed sickle red blood cells. American Journal of Physiology 2006 291 4 H1679 H1685 2-s2.0-33749348212 10.1152/ajpheart.00256.2006 (Pubitemid 44497672)
110. Kuvibidila S., Baliga B. S., Gardner R., Yu L., Warrier R., Velez M., Ode D., Haynes J., Differential effects of hydroxyurea and zileuton on interleukin-13 secretion by activated murine spleen cells: implication on the expression of vascular cell adhesion molecule-1 and vasoocclusion in sickle cell anemia. Cytokine 2005 30 5 213 218 2-s2.0-20144385008 10.1016/j.cyto.2005.01. 010 (Pubitemid 40775838)
111. Haynes J. Jr., Baliga B. S., Obiako B., Ofori-Acquah S., Pace B., Zileuton induces hemoglobin F synthesis in erythroid progenitors: role of the L-arginine-nitric oxide signaling pathway. Blood 2004 103 10 3945 3950 2-s2.0-2342455050 10.1182/blood-2003-08-2969 (Pubitemid 38596317)
112. Haynes J. Jr., Obiako B., Activated polymorphonuclear cells increase sickle red blood cell retention in lung: role of phospholipids. American Journal of Physiology 2002 282 1 H122 H130 2-s2.0-0036086266 (Pubitemid 34654142)
113. Blake K. V., Montelukast: data from clinical trials in the management of asthma. Annals of Pharmacotherapy 1999 33 12 1299 1314 2-s2.0-0033401342 (Pubitemid 30022809)
114. Currie G. P., McLaughlin K., The expanding role of leukotriene receptor antagonists in chronic asthma. Annals of Allergy, Asthma and Immunology 2006 97 6 731 741 2-s2.0-33845929563 (Pubitemid 46032424)
115. Lima J. J., Zhang S., Grant A., Shao L., Tantisira K. G., Allayee H., Wang J., Sylvester J., Holbrook J., Wise R., Weiss S. T., Barnes K., Influence of leukotriene pathway polymorphisms on response to montelukast in asthma. American Journal of Respiratory and Critical Care Medicine 2006 173 4 379 385 2-s2.0-32444440309 10.1164/rccm.200509-1412OC (Pubitemid 43228324)
116. Malmstrom K., Rodriguez-Gomez G., Guerra J., Villaran C., Piñeiro A., Wei L. X., Seidenberg B. C., Reiss T. F., Oral montelukast, inhaled beclomethasone, and placebo for chronic asthma: a randomized, controlled trial. Annals of Internal Medicine 1999 130 6 487 495 (Pubitemid 29135801)
117. Szefler S. J., Phillips B. R., Martinez F. D., Chinchilli V. M., Lemanske R. F., Strunk R. C., Zeiger R. S., Larsen G., Spahn J. D., Bacharier L. B., Bloomberg G. R., Guilbert T. W., Heldt G., Morgan W. J., Moss M. H., Sorkness C. A., Taussig L. M., Characterization of within-subject responses to fluticasone and montelukast in childhood asthma. Journal of Allergy and Clinical Immunology 2005 115 2 233 242 2-s2.0-13444254245 10.1016/j.jaci.2004.11.014 (Pubitemid 40215084)
118. Klotsman M., York T. P., Pillai S. G., Vargas-Irwin C., Sharma S. S., Van Den Oord E. J. C. G., Anderson W. H., Pharmacogenetics of the 5-lipoxygenase biosynthetic pathway and variable clinical response to montelukast. Pharmacogenetics and Genomics 2007 17 3 189 196 2-s2.0-34247561179 10.1097/FPC.0b013e3280120043 (Pubitemid 46668003)
119. Mougey E. B., Feng H., Castro M., Irvin C. G., Lima J. J., Absorption of montelukast is transporter mediated: a common variant of OATP2B1 is associated with reduced plasma concentrations and poor response. Pharmacogenetics and Genomics 2009 19 2 129 138 2-s2.0-59549106159 10.1097/FPC.0b013e32831bd98c
120. Telleria J. J., Blanco-Quiros A., Varillas D., Armentia A., Fernandez-Carvajal I., Jesus Alonso M., Diez I., ALOX5 promoter genotype and response to montelukast in moderate persistent asthma. Respiratory Medicine 2008 102 6 857 861 2-s2.0-43049122378 10.1016/j.rmed.2008.01.011
121. Knorr B., Holland S., Rogers J. D., Nguyen H. H., Reiss T. F., Montelulkast adult (10-mg film-coated tablet) and pediatric (5-mg chewable tablet) dose selections. Journal of Allergy and Clinical Immunology 2000 106 3 S171 S178 2-s2.0-0034532247 (Pubitemid 32015210)
122. Irvin C. G., Kaminsky D. A., Anthonisen N. R., Castro M., Hanania N. A., Holbrook J. T., Lima J. J., Wise R. A., Clinical trial of low-dose theophylline and montelukast in patients with poorly controlled asthma. American Journal of Respiratory and Critical Care Medicine 2007 175 3 235 242 2-s2.0-33846829665 10.1164/rccm.200603-416OC (Pubitemid 46203126)
123. Revicki D. A., Leidy N. K., Brennan-Diemer F., Sorensen S., Togias A., Integrating patient preferences into health outcomes assessment: the multiattribute asthma symptom utility index. Chest 1998 114 4 998 1007 2-s2.0-0031731716 (Pubitemid 28495893)
124. Philip G., Hustad C., Noonan G., Malice M. P., Ezekowitz A., Reiss T. F., Knorr B., Reports of suicidality in clinical trials of montelukast. Journal of Allergy and Clinical Immunology 2009 124 4 691 696.e6 2-s2.0-70449724793 10.1016/j.jaci.2009.08.010
125. Philip G., Hustad C. M., Malice M. P., Noonan G., Ezekowitz A., Reiss T. F., Knorr B., Analysis of behavior-related adverse experiences in clinical trials of montelukast. Journal of Allergy and Clinical Immunology 2009 124 4 699 706.e8 2-s2.0-70449704180 10.1016/j.jaci.2009.08.011
126. Holbrook J. T., Harik-Khan R., Montelukast and emotional well-being as a marker for depression: results from 3 randomized, double-masked clinical trials. Journal of Allergy and Clinical Immunology 2008 122 4 828 829 2-s2.0-53049100875 10.1016/j.jaci.2008.07.012
127. Edwards C. L., Green M., Wellington C. C., Muhammad M., Wood M., Feliu M., Edwards L., Hill L., Sollers J. J., Barksdale C., Robinson E. L., McDougald C. S., Abrams M., Whitfield K. E., Byrd G., Hubbard B., Cola M., DeCastro L., McNeil J., Depression, suicidal ideation, and attempts in black patients with sickle cell disease. Journal of the National Medical Association 2009 101 11 1090 1095 2-s2.0-73349142995
128. Ohaeri J. U., Shokunbi W. A., Akinlade K. S., Dare L. O., The psychosocial problems of sickle cell disease sufferers and their methods of coping. Social Science and Medicine 1995 40 7 955 960 2-s2.0-0028924555 10.1016/0277-9536(94)00154-L
129. Castle W., Fuller R., Hall J., Palmer J., Serevent nationwide surveillance study: comparison of salmeterol with salbutamol in asthmatic patients who require regular bronchodilator treatment. British Medical Journal 1993 306 6884 1034 1037 2-s2.0-0027531892 (Pubitemid 23105961)
130. Nelson H. S., Weiss S. T., Bleecker E. K., Yancey S. W., Dorinsky P. M., The salmeterol multicenter asthma research trial: a comparison of usual pharmacotherapy for asthma or usual pharmacotherapy plus salmeterol. Chest 2006 129 1 15 26 2-s2.0-33144476873 10.1378/chest.129.1.15 (Pubitemid 43265239)
131. Salpeter S. R., Salpeter@stanford.edu Buckley N. S., Ormiston T. M., Salpeter E. E., Meta-analysis: effect of long-acting β -agonists on severe asthma exacerbations and asthma-related deaths. Annals of Internal Medicine 2006 144 12 904 912 (Pubitemid 46768131)
132. Salpeter S. R., Wall A. J., Buckley N. S., Long-acting beta-agonists with and without inhaled corticosteroids and catastrophic asthma events. American Journal of Medicine 2010 123 4 322 328.e2 2-s2.0-77950051793 10.1016/j.amjmed.2009.07.035
133. Mann M., Chowdhury B., Sullivan E., Nicklas R., Anthracite R., Meyer R. J., Serious asthma exacerbations in asthmatics treated with high-dose formoterol. Chest 2003 124 1 70 74 2-s2.0-0038498556 10.1378/chest.124.1.70 (Pubitemid 36851333)
134. Kramer J. M., Balancing the benefits and risks of inhaled long-acting beta-agonists-the influence of values. New England Journal of Medicine 2009 360 16 1592 1595 2-s2.0-64749108978 10.1056/NEJMp0810561
135. 2-adrenergic receptor genotype in subjects with persistent asthma. Journal of Allergy and Clinical Immunology 2006 118 4 809 816 10.1016/j.jaci.2006.06.036 (Pubitemid 44498754)
136. 2-agonist therapy: a pharmacogenetic analysis of two randomised studies. Lancet 2007 370 9605 2118 2125 10.1016/S0140-6736(07) 61906-0 (Pubitemid 350296302)
137. Bleecker E. R., Lawrance R., Ambrose H., Goldman M., Beta2-adrenergic receptor Gly16Arg variation: effect on response to budesonide/formoterol (BUD/FM) or budesonide (BUD; post-formoterol) in children and adolescents with asthma. American Journal of Respiratory and Critical Care Medicine 2008 177, article A776
138. Anderson W., Bacanu S. A., Bleecker E. R., A prospective haplotype analysis of beta2-adrenergic receptor polymorphisms and clinical response to salmeterol and salmeterol/fluticasone propionate. American Journal of Respiratory and Critical Care Medicine 2008 177, article A775
139. 2 agonist in asthma (LARGE trial): a genotype-stratified, randomised, placebo-controlled, crossover trial. The Lancet 2009 374 9703 1754 1764 10.1016/S0140-6736(09)61492-6
140. 2-receptor polymorphisms in patients receiving salmeterol with or without fluticasone propionate. American Journal of Respiratory and Critical Care Medicine 2010 181 7 676 687 2-s2.0-77951886422 10.1164/200809-1511OC
141. Blake K., Murphy S., Kelly H. W., Theophylline. Pediatric Asthma 1999 New York Marcel Dekker 363 431
142. Kumar R., Qureshi S., Mohanty P., Rao S. P., Miller S. T., A short course of prednisone in the management of acute chest syndrome of sickle cell disease. Journal of Pediatric Hematology/Oncology 2010 32 3 e91 e94 2-s2.0-77951093004 10.1097/MPH.0b013e3181c29c52
143. Sobota A., Graham D. A., Heeney M. M., Neufeld E. J., Corticosteroids for acute chest syndrome in children with sickle cell disease: variation in use and association with length of stay and readmission. American Journal of Hematology 2010 85 1 24 28 2-s2.0-74049124514 10.1002/ajh.21565
144. Darbari D. S., Castro O., Taylor J. G., Fasano R., Rehm J., Gordeuk V. R., Minniti C. P., Severe vaso-occlusive episodes associated with use of systemic corticosteroids in patients with sickle cell disease. Journal of the National Medical Association 2008 100 8 948 951 2-s2.0-50049106076
145. Strouse J. J., jstrous1@jhmi.edu Takemoto C. M., Keefer J. R., Kato G. J., Casella J. F., Corticosteroids and increased risk of readmission after acute chest syndrome in children with sickle cell disease. Pediatric Blood and Cancer 2008 50 5 1006 1012 10.1002/pbc.21336 (Pubitemid 351500179)
146. Isakoff M. S., Lillo J. A., Hagstrom J. N., A single-institution experience with treatment of severe acute chest syndrome: lack of rebound pain with dexamethasone plus transfusion therapy. Journal of Pediatric Hematology/Oncology 2008 30 4 322 325 2-s2.0-41949090878 10.1097/MPH. 0b013e3181647bb2 (Pubitemid 351507590)
147. Celano M. P., Linzer J. F., Demi A., Bakeman R., Smith C. O., Croft S., Kobrynski L. J., Treatment adherence among low-income, african american children with persistent asthma. Journal of Asthma 2010 47 3 317 322 2-s2.0-77951127894 10.3109/02770900903580850
148. Hendeles L., Asmus M., Chesrown S., What is the role of budesonide inhalation suspension for nebulization? The Journal of Pediatric Pharmacology and Therapeutics 2001 6 162 166
149. Rand C., Bilderback A., Schiller K., Edelman J. M., Hustad C. M., Zeiger R. S., Adherence with montelukast or fluticasone in a long-term clinical trial: results from the mild asthma montelukast versus inhaled corticosteroid trial. Journal of Allergy and Clinical Immunology 2007 119 4 916 923 2-s2.0-34047248519 10.1016/j.jaci.2006.12.664 (Pubitemid 46546427)